Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rob Ter Heine

Showing results (81-90 of 160) with videos related to

Pageof 16
Sort By:
British Journal of Clinical Pharmacology|December 24, 2010
Erlotinib and pantoprazole: a relevant interaction or not?Rob Ter Heine, James C Fanggiday, Nienke A G Lankheet, et al.
European Journal of Clinical Pharmacology|August 17, 2024
Model-informed dose optimization of mycophenolic acid in pediatric kidney transplant patientsAstrid Heida, Nynke G L Jager, Rob E Aarnoutse, et al.
British Journal of Clinical Pharmacology|May 17, 2020
Prospective validation of a model-informed precision dosing tool for vancomycin in intensive care patientsRob Ter Heine, Ron J Keizer, Krista van Steeg, et al.
Journal of Child Neurology|May 15, 2013
The quantitative effect of serum albumin, serum urea, and valproic acid on unbound phenytoin concentrations in childrenRob ter Heine, Erik M van Maarseveen, Monique M L van der Westerlaken, et al.
International Journal of Antimicrobial Agents|July 18, 2020
Reply to Gautret et al: hydroxychloroquine sulfate and azithromycin for COVID-19: what is the evidence and what are the risks?Julian D Machiels, Chantal P Bleeker-Rovers, Rob Ter Heine, et al.
Clinical Pharmacokinetics|June 25, 2025
Model-Informed Precision Dosing of Eculizumab in Patients with Paroxysmal Nocturnal HemoglobinuriaMendy Ter Avest, Saskia M C Langemeijer, Lambertus P W J van den Heuvel, et al.
Cancer Chemotherapy and Pharmacology|December 20, 2019
A limited sampling schedule to estimate individual pharmacokinetics of pemetrexed in patients with varying renal functionsNikki de Rouw, Sabine Visser, Stijn L W Koolen, et al.
Clinical Pharmacokinetics|February 2, 2017
Population Pharmacokinetic Model and Pharmacokinetic Target Attainment of Micafungin in Intensive Care Unit PatientsLisa C Martial, Rob Ter Heine, Jeroen A Schouten, et al.
Cancer Biotherapy & Radiopharmaceuticals|January 25, 2017
Cytotoxic Effects of the Therapeutic Radionuclide Rhenium-188 Combined with Taxanes in Human Prostate Carcinoma Cell LinesRogier Lange, Rob ter Heine, Wessel N van Wieringen, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|June 15, 2022
Practical recommendations to combine small-molecule inhibitors and direct oral anticoagulants in patients with nonsmall cell lung cancerLeila S Otten, Berber Piet, Michel M van den Heuvel, et al.
Pageof 16

Showing results (81-90 of 160) with videos related to

Sort By:
Pageof 16
British Journal of Clinical Pharmacology|December 24, 2010
Erlotinib and pantoprazole: a relevant interaction or not?Rob Ter Heine, James C Fanggiday, Nienke A G Lankheet, et al.
European Journal of Clinical Pharmacology|August 17, 2024
Model-informed dose optimization of mycophenolic acid in pediatric kidney transplant patientsAstrid Heida, Nynke G L Jager, Rob E Aarnoutse, et al.
British Journal of Clinical Pharmacology|May 17, 2020
Prospective validation of a model-informed precision dosing tool for vancomycin in intensive care patientsRob Ter Heine, Ron J Keizer, Krista van Steeg, et al.
Journal of Child Neurology|May 15, 2013
The quantitative effect of serum albumin, serum urea, and valproic acid on unbound phenytoin concentrations in childrenRob ter Heine, Erik M van Maarseveen, Monique M L van der Westerlaken, et al.
International Journal of Antimicrobial Agents|July 18, 2020
Reply to Gautret et al: hydroxychloroquine sulfate and azithromycin for COVID-19: what is the evidence and what are the risks?Julian D Machiels, Chantal P Bleeker-Rovers, Rob Ter Heine, et al.
Clinical Pharmacokinetics|June 25, 2025
Model-Informed Precision Dosing of Eculizumab in Patients with Paroxysmal Nocturnal HemoglobinuriaMendy Ter Avest, Saskia M C Langemeijer, Lambertus P W J van den Heuvel, et al.
Cancer Chemotherapy and Pharmacology|December 20, 2019
A limited sampling schedule to estimate individual pharmacokinetics of pemetrexed in patients with varying renal functionsNikki de Rouw, Sabine Visser, Stijn L W Koolen, et al.
Clinical Pharmacokinetics|February 2, 2017
Population Pharmacokinetic Model and Pharmacokinetic Target Attainment of Micafungin in Intensive Care Unit PatientsLisa C Martial, Rob Ter Heine, Jeroen A Schouten, et al.
Cancer Biotherapy & Radiopharmaceuticals|January 25, 2017
Cytotoxic Effects of the Therapeutic Radionuclide Rhenium-188 Combined with Taxanes in Human Prostate Carcinoma Cell LinesRogier Lange, Rob ter Heine, Wessel N van Wieringen, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|June 15, 2022
Practical recommendations to combine small-molecule inhibitors and direct oral anticoagulants in patients with nonsmall cell lung cancerLeila S Otten, Berber Piet, Michel M van den Heuvel, et al.
Pageof 16